The content is available as a PDF (1.1 MB).
Tu1551: PATIENTS WITH INFLAMMATORY BOWEL DISEASES HAVE IMPAIRED ANTIBODY PRODUCTION AFTER ANTI-SARS-COV-2 VACCINATION, ESPECIALLY THOSE ON ANTI-TNFα OR COMBINATION TREATMENT OF BIOLOGICS PLUS IMMUNOMODULATORS: RESULTS FROM A PANHELLENIC REGISTRY
Eirini Zacharopoulou
Eleni Orfanoudaki
Vassiliki Kitsou
Maria Tzouvala
George Tribonias
Gerassimos J Mantzaris
Nikos Viazis
Angeliki Christidou
Tereza Georgiadi
Konstantinos Karmiris
Angeliki Theodoropoulou
Maria Tsafaridou
Spyridon Michopoulos
Evanthia Zampeli
Evgenia Papathanasiou
Georgios Michalopoulos
Stefanos Tigkas
Pantelis Karatzas
Effrosyni Laoudi
Christos Liatsos
Nikolaos Kyriakos
Iordanis Mylonas
Georgios J Theocharis
Theodora Kafentzi
Ioannis E Koutroubakis
Giorgos Bamias
Issue date 2022 May.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
